Cargando…

Medicaid Policies for HIV-Related Prescription Drugs

As State Medicaid programs become increasingly important sources of payment for acquired immunodeficiency syndrome (AIDS)-related care, and drug regimens the major weapons available to fight human immunodeficiency virus (HIV)-related illnesses, Medicaid drug policies will have a substantial impact....

Descripción completa

Detalles Bibliográficos
Autores principales: Buchanan, Robert J., Smith, Scott R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: CENTERS for MEDICARE & MEDICAID SERVICES 1994
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193452/
https://www.ncbi.nlm.nih.gov/pubmed/10137797
_version_ 1782338978123350016
author Buchanan, Robert J.
Smith, Scott R.
author_facet Buchanan, Robert J.
Smith, Scott R.
author_sort Buchanan, Robert J.
collection PubMed
description As State Medicaid programs become increasingly important sources of payment for acquired immunodeficiency syndrome (AIDS)-related care, and drug regimens the major weapons available to fight human immunodeficiency virus (HIV)-related illnesses, Medicaid drug policies will have a substantial impact. State Medicaid programs were surveyed to identify policies on a range of prescription drug policies affecting these recipients. All Medicaid programs provide prescription drug benefits to all categorically needy recipients, and about three-fourths of the States provide these benefits to medically needy recipients. However, utilization limits, copayments, and off-label-use and prior-authorization policies in many States weaken the drug benefit available.
format Online
Article
Text
id pubmed-4193452
institution National Center for Biotechnology Information
language English
publishDate 1994
publisher CENTERS for MEDICARE & MEDICAID SERVICES
record_format MEDLINE/PubMed
spelling pubmed-41934522014-11-04 Medicaid Policies for HIV-Related Prescription Drugs Buchanan, Robert J. Smith, Scott R. Health Care Financ Rev Prescription Drugs: Payment and Policy Issues As State Medicaid programs become increasingly important sources of payment for acquired immunodeficiency syndrome (AIDS)-related care, and drug regimens the major weapons available to fight human immunodeficiency virus (HIV)-related illnesses, Medicaid drug policies will have a substantial impact. State Medicaid programs were surveyed to identify policies on a range of prescription drug policies affecting these recipients. All Medicaid programs provide prescription drug benefits to all categorically needy recipients, and about three-fourths of the States provide these benefits to medically needy recipients. However, utilization limits, copayments, and off-label-use and prior-authorization policies in many States weaken the drug benefit available. CENTERS for MEDICARE & MEDICAID SERVICES 1994 /pmc/articles/PMC4193452/ /pubmed/10137797 Text en
spellingShingle Prescription Drugs: Payment and Policy Issues
Buchanan, Robert J.
Smith, Scott R.
Medicaid Policies for HIV-Related Prescription Drugs
title Medicaid Policies for HIV-Related Prescription Drugs
title_full Medicaid Policies for HIV-Related Prescription Drugs
title_fullStr Medicaid Policies for HIV-Related Prescription Drugs
title_full_unstemmed Medicaid Policies for HIV-Related Prescription Drugs
title_short Medicaid Policies for HIV-Related Prescription Drugs
title_sort medicaid policies for hiv-related prescription drugs
topic Prescription Drugs: Payment and Policy Issues
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4193452/
https://www.ncbi.nlm.nih.gov/pubmed/10137797
work_keys_str_mv AT buchananrobertj medicaidpoliciesforhivrelatedprescriptiondrugs
AT smithscottr medicaidpoliciesforhivrelatedprescriptiondrugs